Hollenbeck Scott T, Sakakibara Kenji, Faries Peter L, Workhu Berhane, Liu Bo, Kent K Craig
Department of Surgery, Division of Vascular Surgery, Weill Medical College of Cornell University, 525 East 68th Street, Payson 707, New York, NY 1002, USA.
J Surg Res. 2004 Aug;120(2):288-94. doi: 10.1016/j.jss.2004.01.005.
Stem cell factor (SCF) is a membrane-bound and soluble growth factor that activates the c-kit tyrosine kinase receptor. Given the similarities between c-kit and platelet-derived growth factor (PDGF) receptors, we hypothesized that similar to PDGF, SCF/c-kit signaling may play a role in smooth muscle cell (SMC) function and thus the development of intimal hyperplasia.
Human saphenous vein SMCs were harvested from veins procured at the time of bypass grafting. Carotid arteries from rats that were balloon injured (n = 12) at variable time points were compared to sham-operated controls (n = 3). Expression of SCF and c-kit was measured by immunohistochemistry (IHC) and Western blotting.
Western blotting revealed that human SMCs express membrane-bound SCF. In separate experiments, we found that this growth factor undergoes proteolytic cleavage to its soluble form following exposure to matrix metalloproteinase-9 (MMP-9), a ubiquitous MMP released at the time of arterial injury. We next evaluated in human SMCs, expression of the SCF receptor, c-kit. Western blotting of human SMC lysates revealed minor but consistent expression of c-kit. IHC demonstrated c-kit expression to be localized to the media. To determine if c-kit is up-regulated during the development of intimal hyperplasia, we evaluated expression of this receptor in a rat carotid balloon injury model. Quantification of IHC staining on injured vessels revealed that c-kit expression within the media was significantly increased at 3, 7, 14, and 28 days following injury (28.1, 30.8, 16, and 10.4% increase over sham controls, respectively, P < 0.05). Furthermore, c-kit expression was prominent within the neointima and maximal at 7 days (53.4 +/- 7.8% of area c-kit positive).
Human vascular SMCs express the growth factor SCF and its receptor, c-kit. SCF is released from its membrane-bound form via MMP-9. This finding and the dramatic increase in c-kit expression observed in the rat carotid artery after balloon injury suggests SCF/c-kit signaling may affect SMC function via an autocrine pathway.
干细胞因子(SCF)是一种膜结合型和可溶性生长因子,可激活c-kit酪氨酸激酶受体。鉴于c-kit与血小板衍生生长因子(PDGF)受体之间的相似性,我们推测,与PDGF类似,SCF/c-kit信号传导可能在平滑肌细胞(SMC)功能及内膜增生发展过程中发挥作用。
人隐静脉SMC取自旁路移植时获取的静脉。将在不同时间点接受球囊损伤的大鼠(n = 12)的颈动脉与假手术对照组(n = 3)进行比较。通过免疫组织化学(IHC)和蛋白质印迹法检测SCF和c-kit的表达。
蛋白质印迹法显示人SMC表达膜结合型SCF。在单独实验中,我们发现该生长因子在暴露于基质金属蛋白酶-9(MMP-9,一种在动脉损伤时释放的普遍存在的MMP)后会被蛋白水解切割成其可溶性形式。接下来,我们评估了人SMC中SCF受体c-kit的表达。人SMC裂解物的蛋白质印迹法显示c-kit有少量但持续的表达。IHC表明c-kit表达定位于中膜。为确定c-kit在内膜增生发展过程中是否上调,我们在大鼠颈动脉球囊损伤模型中评估了该受体的表达。对损伤血管的IHC染色定量显示,损伤后3、7、14和28天,中膜内的c-kit表达显著增加(分别比假手术对照组增加28.1%、30.8%、16%和10.4%,P < 0.05)。此外,c-kit在新生内膜中表达显著,在7天时达到最高(c-kit阳性区域占53.4 +/- 7.8%)。
人血管SMC表达生长因子SCF及其受体c-kit。SCF通过MMP-9从其膜结合形式释放。这一发现以及在大鼠颈动脉球囊损伤后观察到的c-kit表达显著增加表明,SCF/c-kit信号传导可能通过自分泌途径影响SMC功能。